Cambridge Nucleomics

Cambridge Nucleomics

Biotechnology

Pioneering Biosensing Platform Technology for the RNA Era of Personalised and Precision Medicine

About us

Cambridge Nucleomics is a biotech spinoff from the University of Cambridge. We help big pharmas, biotech companies and clinical researchers with a unique value proposition for accurate, fast and direct quantification of native RNA. Our mission is to quantify all short and long RNAs in one simple measurement by 2025, with the vision to build an innovative platform technology company for the RNA era of personalised and precision medicine.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Cambridge
Type
Self-Employed

Locations

Employees at Cambridge Nucleomics

Updates

Similar pages

Browse jobs